Related Articles by Review for PMID: 16735673

Year	Number of Results
2002	2
2004	4
2005	4
2006	1
2007	1
2008	2
2009	5
2010	2
2011	4
2012	1
2013	2
2014	3
2015	5
2016	2
2017	1
2018	2
2019	4
2020	4
2022	1
2023	2
2024	0

1

Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy.

Kong Y, Tannous P, Lu G, Berenji K, Rothermel BA, Olson EN, Hill JA. Kong Y, et al. Circulation. 2006 Jun 6;113(22):2579-88. doi: 10.1161/CIRCULATIONAHA.106.625467. Epub 2006 May 30. Circulation. 2006. PMID: 16735673 Free PMC article.

2

Drug insight: Histone deacetylase inhibitors--development of the new targeted anticancer agent suberoylanilide hydroxamic acid.

Kelly WK, Marks PA. Kelly WK, et al. Nat Clin Pract Oncol. 2005 Mar;2(3):150-7. doi: 10.1038/ncponc0106. Nat Clin Pract Oncol. 2005. PMID: 16264908 Review.

3

Role of histone deacetylase inhibitors in the treatment of cancer (Review).

Mei S, Ho AD, Mahlknecht U. Mei S, et al. Int J Oncol. 2004 Dec;25(6):1509-19. Int J Oncol. 2004. PMID: 15547685 Review.

4

Histone deacetylase inhibition in the treatment of heart disease.

Berry JM, Cao DJ, Rothermel BA, Hill JA. Berry JM, et al. Expert Opin Drug Saf. 2008 Jan;7(1):53-67. doi: 10.1517/14740338.7.1.53. Expert Opin Drug Saf. 2008. PMID: 18171314 Review.

5

Targeting histone deacetylases for heart failure.

Bush EW, McKinsey TA. Bush EW, et al. Expert Opin Ther Targets. 2009 Jul;13(7):767-84. doi: 10.1517/14728220902939161. Expert Opin Ther Targets. 2009. PMID: 19466913 Review.

6

Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy.

Kee HJ, Kook H. Kee HJ, et al. J Biomed Biotechnol. 2011;2011:928326. doi: 10.1155/2011/928326. Epub 2010 Nov 29. J Biomed Biotechnol. 2011. PMID: 21151616 Free PMC article. Review.

7

Therapeutic effects of histone deacetylase inhibitors on heart disease.

Chun P. Chun P. Arch Pharm Res. 2020 Dec;43(12):1276-1296. doi: 10.1007/s12272-020-01297-0. Epub 2020 Nov 27. Arch Pharm Res. 2020. PMID: 33245518 Review.

8

Non-sirtuin histone deacetylases in the control of cardiac aging.

Ferguson BS, McKinsey TA. Ferguson BS, et al. J Mol Cell Cardiol. 2015 Jun;83:14-20. doi: 10.1016/j.yjmcc.2015.03.010. Epub 2015 Mar 16. J Mol Cell Cardiol. 2015. PMID: 25791169 Free PMC article. Review.

9

Histone deacetylases in cardiovascular and metabolic diseases.

Bagchi RA, Weeks KL. Bagchi RA, et al. J Mol Cell Cardiol. 2019 May;130:151-159. doi: 10.1016/j.yjmcc.2019.04.003. Epub 2019 Apr 9. J Mol Cell Cardiol. 2019. PMID: 30978343 Review.

10

Targeting histone deacetylases in endometrial cancer: a paradigm-shifting therapeutic strategy?

Garmpis N, Damaskos C, Garmpi A, Spartalis E, Kalampokas E, Kalampokas T, Margonis GA, Schizas D, Andreatos N, Angelou A, Lavaris A, Athanasiou A, Apostolou KG, Spartalis M, Damaskou Z, Daskalopoulou A, Diamantis E, Tsivelekas K, Alavanos A, Valsami S, Moschos MM, Sampani A, Nonni A, Antoniou EA, Mantas D, Tsourouflis G, Markatos K, Kontzoglou K, Perrea D, Nikiteas N, Kostakis A, Dimitroulis D. Garmpis N, et al. Eur Rev Med Pharmacol Sci. 2018 Feb;22(4):950-960. doi: 10.26355/eurrev_201802_14376. Eur Rev Med Pharmacol Sci. 2018. PMID: 29509243 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

46 results

Results by year